Brief: Sienna Biopharmaceuticals Appoints John Smither As CFO
March 21 (Reuters) - Sienna Biopharmaceuticals Inc SNNA.O :
* SIENNA BIOPHARMACEUTICALS APPOINTS JOHN W. SMITHER AS
CHIEF
FINANCIAL OFFICER
* SIENNA BIOPHARMACEUTICALS INC - SMITHER WILL SUCCEED
RICHARD
PETERSON, WHO HAS RESIGNED FOR PERSONAL REASONS, EFFECTIVE MAR.
29, 2018
Source text for Eikon: ID:nGNX1sQDMM
Further company coverage: SNNA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sienna Biopharmaceuticals
See all newsU.S. STOCKS ON THE MOVE-Adobe, Oracle, Snap, Phreesia, Sarepta, Aquestive Therapeutics, Patterson-UTI
U.S. STOCKS ON THE MOVE-Lululemon, GE, Starbucks, Delta Air Lines, Lumber Liquidators, Lovesac
Sienna Biopharma: Falls on Nasdaq delisting plans
Brief: Sienna Biopharma Says Bankruptcy Court Approved Sale Of Assets Related To SNA-001 For $1.7 Mln In Cash
Brief: Sienna Biopharmaceuticals Announces Court Approval Of Chapter 11 Bidding Procedures